Rigaku (The Woodlands, Texas) has acquired the crystallization reagent and consumables business, including crystallization screening kits, from Emerald Bio (Bainbridge Island, Washington). The companies have agreed to work together to develop new products and solutions for the field of protein science.
Rigaku (The Woodlands, Texas) has acquired the crystallization reagent and consumables business, including crystallization screening kits, from Emerald Bio (Bainbridge Island, Washington). The companies have agreed to work together to develop new products and solutions for the field of protein science.
“The addition of these consumables and screening kits is another step in creating a single contact point for our instrumentation customers, improving the efficiency of their workflow,” said Catherine Klein, president of Rigaku Americas Corporation’s Life Sciences Division. “Further, having Emerald Bio as a development partner and customer will help ensure that we are at the forefront of new product needs in protein science.”
“Having Rigaku, the world leading protein crystallography instrumentation company, as a development partner is ideal for Emerald,” said Johan Pontin, CEO of Emerald Bio.
